Want to see KLRS full AI Analyst Report?
Kalaris Therapeutics (KLRS) Ownership Overview
54.44% Insiders
1.98% Mutual Funds
4.37% Other Institutional Investors
1.14% ETFs
38.07% Public Companies and
Individual Investors
The ownership structure of Kalaris Therapeutics (KLRS) stock is a mix of institutional, retail, and individual investors. Approximately 7.49% of the company’s stock is owned by Institutional Investors, 54.44% is owned by Insiders, and 38.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 22, 2026 | xxxxxxxxxxxxx | $1179969 | |
Mar 23, 2026 | xxxxxxxxxxxxx | $12869 | |
Feb 17, 2026 | xxxxxxxxxxxxx | $5000006 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 19,677,546 | Insider | 82.66% | 39,945,418 | |
| 12,915,520 | Insider | 54.26% | 26,218,506 | |
| 504,000 | Insider | 2.12% | 1,023,120 | |
| 392,710 | Institution | 1.65% | 797,201 | |
| 324,926 | Institution | 1.36% | 659,600 | |
| 100,000 | Institution | 0.42% | 203,000 | |
| 93,856 | Institution | 0.39% | 190,528 | |
| 74,608 | Institution | 0.31% | 151,454 | |
| 32,500 | Institution | 0.14% | 65,975 | |
| 30,838 | Institution | 0.13% | 62,601 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 392,710 | Institution | 1.65% | 797,201 | |
| 93,856 | Institution | 0.39% | 190,528 | |
| 74,608 | Institution | 0.31% | 151,454 | |
| 32,500 | Institution | 0.14% | 65,975 | |
| 30,838 | Institution | 0.13% | 62,601 | |
| 30,074 | Institution | 0.13% | 61,050 | |
| 6,002 | Institution | 0.03% | 12,184 | |
| 5,300 | Institution | 0.02% | 10,759 | |
| 4,994 | Institution | 0.02% | 10,138 | |
| 2,750 | Institution | 0.01% | 5,582 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 255,337 | Institution | 1.07% | 737,924 | |
| 69,589 | Institution | 0.29% | 201,112 | |
| 27,597 | Institution | 0.12% | 55,470 | |
| 22,500 | Institution | 0.09% | 45,225 | |
| 3,296 | Institution | 0.01% | 6,625 | |
| 2,614 | Institution | 0.01% | 5,254 | |
| 384 | Institution | <0.01% | 1,065 | |
| 255 | Institution | <0.01% | 707 | |
| 100 | Institution | <0.01% | 201 |
FAQ
Who Owns Kalaris Therapeutics (KLRS)?
According to the latest TipRanks data, approximately 4.37% of the company's stock is held by institutional investors, 54.44% is held by insiders, and 38.07% is held by retail investors.
What percentage of Kalaris Therapeutics (KLRS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.37% of Kalaris Therapeutics (KLRS) stock is held by institutional investors.
What percentage of Kalaris Therapeutics (KLRS) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.07% of Kalaris Therapeutics (KLRS) stock is held by retail investors.
Who owns the most shares of Kalaris Therapeutics (KLRS)?
David Hallal owns the most shares of Kalaris Therapeutics (KLRS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.